Evaluation of specialized medication packaging combined with medication therapy management: Adherence, outcomes, and costs among medicaid patients

Medical Care

Volumn 50, Issue 6, 2012, Pages 485-493

  Zillich, Alan J ^a   Jaynes, Heather A W ^a   Snyder, Margie E ^a   Harrison, Jeff ^b   Hudmon, Karen Suchanek ^a   De Moor, Carl ^c   French, Dustin D ^a  

^a PURDUE UNIVERSITY   (United States)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

^c Epidemiology NA   (United States)

Author keywords

Adherence; Medicaid; Outcomes; Pharmacy service

Indexed keywords

ADULT; AGED; COHORT ANALYSIS; DRUG COST; DRUG PACKAGING; EMERGENCY WARD; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH PROGRAM; HEALTH SERVICE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAID; MEDICATION THERAPY MANAGEMENT; MULTIVARIATE ANALYSIS; OUTCOMES RESEARCH; PATIENT COMPLIANCE; PHARMACIST; PHARMACY; PRIORITY JOURNAL; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; REVIEW; STATISTICAL MODEL; TELEPHONE;

ADOLESCENT; ADULT; AGED; COMMUNITY PHARMACY SERVICES; DRUG PACKAGING; FEMALE; HEALTH CARE COSTS; HEALTH EXPENDITURES; HEALTH SERVICES; HUMANS; MALE; MEDICAID; MEDICATION ADHERENCE; MEDICATION THERAPY MANAGEMENT; MIDDLE AGED; RETROSPECTIVE STUDIES; TELEPHONE; UNITED STATES;

EID: 84861226730     PISSN: 00257079     EISSN: 15371948     Source Type: Journal    
DOI: 10.1097/MLR.0b013e3182549d48     Document Type: Review

References (46)

1. Ernst FR, Grizzle AJ. Drug-related morbidity and mortality: updating the cost-of-illness model. J Am Pharm Assoc (Wash). 2001;41:192-199.
2. Bluml BM. Definition of medication therapy management: development of professionwide consensus. J Am Pharm Assoc (2003). 2005;45: 566-572. (Pubitemid 46037267)
3. 2010 CMS MTM Fact Sheet. [cited December 5, 2001]. Available at: https://www.cms.gov/PrescriptionDrugCovContra/Downloads/MTMFact Sheet-2010-06-2010-final.pdf. Accessed December 5, 2011.
4. Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990;47:533-543. (Pubitemid 20138134)
5. American Pharmacists Association and the National Association of Chain Drug Stores Foundation. Medication therapy management in pharmacy practice: core elements of an MTM service model (version 2.0). J Am Pharm Assoc. 2008;48:341-353.
6. Centers for Medicare and Medicaid Services. Department of Health and Human Services. Medicare prescription drug benefit final rule. Fed Regist. 2005;70:4194-4585.
7. Cranor CW, Bunting BA, Christensen DB. The Asheville Project: longterm clinical and economic outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc (Wash). 2003;43:173-184.
8. Fera T, Bluml BM, Ellis WM. Diabetes ten city challenge: final economic and clinical results. J Am Pharm Assoc (2003). 2009;49:383-391.
9. Isetts BJ, Schondelmeyer SW, Artz MB, et al. Clinical and economic outcomes of medication therapy management services: the Minnesota experience. J Am Pharm Assoc. 2008;48:203-211.
10. Pindolia VK, Stebelsky L, Romain TM, et al. Mitigation of medication mishaps via medication therapy management. Ann Pharmacother. 2009;43:611-620.
11. Planas LG, Crosby KM, Mitchell KD, et al. Evaluation of a hypertension medication therapy management program in patients with diabetes. J Am Pharm Assoc. 2009;49:164-170.
12. Doucette WR, McDonough RP, Klepser D, et al. Comprehensive medication therapy management: identifying and resolving drug-related issues in a community pharmacy. Clin Ther. 2005;27:1104-1111. (Pubitemid 41262469)
13. Hirsch JD, Rosenquist A, Best BM, et al. Evaluation of the first year of a pilot program in community pharmacy: HIV/AIDS medication therapy management for Medi-Cal beneficiaries. J Manag Care Pharm. 2009;15:32-41.
14. Isetts BJ. Evaluating effectiveness of the Minnesota Medication Therapy Management Care Program. Final report to Medicaid. 2007. Available at: http://www.dhs.state.mn.us/main/groups/business-partners/documents/pub/ dhs16-140283.pdf. Accessed March 1, 2011.
15. Michaels NM, Jenkins GF, Pruss DL, et al. Retrospective analysis of community pharmacists' recommendations in the North Carolina Medicaid medication therapy management program. J Am Pharm Assoc (2003). 2010;50:347-353.
16. Ramalho de Oliveira D, Brummel AR, Miller DB. Medication therapy management: 10 years of experience in a large integrated health care system. J Manag Care Pharm. 2010;16:185-195.
17. Haynes RB, Ackloo E, Sahota N, et al. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2008;2:CD000011.
18. Kripalani S, Yao X, Haynes RB. Interventions to enhance medication adherence in chronic medical conditions: a systematic review. Arch Intern Med. 2007;167:540-550. (Pubitemid 46513223)
19. Cipolle RJ, Strand LM, Morley PC. Pharmaceutical Care Practice: The Clinician's Guide. 2nd Edition. New York: McGraw-Hill, Medical Division; 2004.
20. Indiana Medicaid. Indiana Care Select-(Medicaid Care Management for Aged, Blind, Disabled) and Prior Authorization Changes. Indiana Medicaid Provider Bulletin. September 13th, 2007. Available from: http://provider.indianamedicaid. com/ihcp/bulletins/bt200723.pdf. Accessed March 29, 2012.
21. Elixhauser A, Steiner C, Harris DR, et al. Comorbidity measures for use with administrative data. Med Care. 1998;36:8-27. (Pubitemid 128456396)
22. Cramer JA, Roy A, Burrell A, et al. Medication compliance and persistence: terminology and definitions. Value Health. 2008;11:44-47. (Pubitemid 351160875)
23. Steiner JF, Prochazka AV. The assessment of refill compliance using pharmacy records: methods, validity, and applications. J Clin Epidemiol. 1997;50:105-116. (Pubitemid 27089212)
24. Peterson AM, Nau DP, Cramer JA, et al. A checklist for medication compliance and persistence studies using retrospective databases. Value Health. 2007;10:3-12. (Pubitemid 46161090)
25. Sikka R, Xia F, Aubert RE. Estimating medication persistency using administrative claims data. Am J Manag Care. 2005;11:449-457. (Pubitemid 41022729)
26. Prevention Quality Indicators overview. Agency for Healthcare Research and Quality [Accessed March 29, 2012]; Available from: http://www. qualityindicators.ahrq.gov/Modules/pqi-overview.aspx.
27. Blough DK, Ramsey SD. Using generalized linear models to assess medical care costs. Health Serv Outcome Res Methodology. 2000; 1:185-202. (Pubitemid 32798848)
28. Buntin MB, Zaslavsky AM. Too much ado about two-part models and transformation? Comparing methods of modeling Medicare expenditures. J Health Econ. 2004;23:525-542. (Pubitemid 38569537)
29. Manning WG, Mullahy J. Estimating log models: to transform or not to transform? J Health Econ. 2001;20:461-494. (Pubitemid 32515166)
30. Heneghan CJ, Glasziou PP, Perera R. Reminder packaging for improving adherence to self-administered long-term medications. Cochrane Database Syst Rev. 2006;1:CD005025.
31. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353:487-497. (Pubitemid 41127293)
32. Roter DL, Hall JA, Merisca R, et al. Effectiveness of interventions to improve patient compliance: a meta-analysis. Med Care. 1998;36:1138-1161. (Pubitemid 128456406)
33. McDonald HP, Garg AX, Haynes RB. Interventions to enhance patient adherence to medication prescriptions: scientific review. JAMA. 2002;288:2868-2879. (Pubitemid 35425073)
34. Sokol MC, McGuigan KA, Verbrugge RR, et al. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care. 2005;43:521-530. (Pubitemid 40847288)
35. Vik SA, Maxwell CJ, Hogan DB. Measurement, correlates, and health outcomes of medication adherence among seniors. Ann Pharmacother. 2004;38:303-312. (Pubitemid 38112246)
36. Wu JY, Leung WY, Chang S, et al. Effectiveness of telephone counselling by a pharmacist in reducing mortality in patients receiving polypharmacy: randomised controlled trial. BMJ. 2006;333: 522-527.
37. Lee JK, Grace KA, Taylor AJ. Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: a randomized controlled trial. JAMA. 2006; 296:2563-2571. (Pubitemid 44903860)
38. Choudhry NK, Fischer MA, Avorn J, et al. The implications of therapeutic complexity on adherence to cardiovascular medications. Arch Intern Med. 2011;171:814-822.
39. Smith M, Giuliano MR, Starkowski MP. In Connecticut: improving patient medication management in primary care. Health Aff (Millwood). 2011;30:646-654.
40. Lounsbery JL, Green CG, Bennett MS, et al. Evaluation of pharmacists' barriers to the implementation of medication therapy management services. J Am Pharm Assoc (2003). 2009;49:51-58.
41. Brock KA, Doucette WR. Collaborative working relationships between pharmacists and physicians: an exploratory study. J Am Pharm Assoc (2003). 2004;44:358-365.
42. Doucette WR, Nevins J, McDonough RP. Factors affecting collaborative care between pharmacists and physicians. Res Social Adm Pharm. 2005;1:565-578. (Pubitemid 44061739)
43. Snyder ME, Zillich AJ, Primack BA, et al. Exploring successful community pharmacist-physician collaborative working relationships using mixed methods. Res Social Adm Pharm. 2010;6:307-323.
44. Zillich AJ, McDonough RP, Carter BL, et al. Influential characteristics of physician/pharmacist collaborative relationships. Ann Pharmacother. 2004;38:764-770. (Pubitemid 38509049)
45. Brookhart MA, Patrick AR, Dormuth C, et al. Adherence to lipidlowering therapy and the use of preventive health services: an investigation of the healthy user effect. Am J Epidemiol. 2007;166: 348-354. (Pubitemid 47216808)
46. Indiana Family and Social Services. Changes to the Care Select Program Annouced. 2010 Available from: http://provider.indianamedicaid.com/news,- bulletins,-and-banners/archived-news-2010/changes-to-the-careselect-program- announced.aspx. [Accessed March 29, 2012].